Advertisement
News
Advertisement

Second Sight Medical Products’ Argus II Named Invention of the Year by Popular Science Magazine

Wed, 11/13/2013 - 11:08am
Business Wire

Second Sight Medical Products, Inc., the leading developer of retinal prostheses for the blind, is pleased to announce that its Argus II Retinal Prosthesis System (Argus II), has been recognized by Popular Science magazine as ‘Invention of the Year.’

Each year, the editors of Popular Science review thousands of products in search of the top 100 tech innovations of the year—breakthrough products and technologies that represent a significant leap in their categories. The winners, the Best of What's New, are awarded inclusion in the much-anticipated December issue of Popular Science, the most widely read issue of the year since the debut of Best of What's New in 1988. Best of What’s New awards are presented to 100 new products and technologies in 12 categories: Automotive, Aviation, Computing, Engineering, Gadgets, Green, Entertainment, Security, Software, Home, Health and Recreation. Argus II not only made the best of what’s new list, but took top honor in Health, and was deemed the invention of the year for 2013.

“We are extremely honored to receive this award from Popular Science,” said Robert Greenberg, MD, PhD, President and CEO of Second Sight. “We look forward to sharing our innovation with the many people with advanced Retinitis Pigmentosa as we prepare for our official launch here in the US.”

“For more than a quarter century, Popular Science has devoted its December issue to the year's most remarkable innovations. The Best of What's New Awards is our magazine's top honor, and the 100 awardees are selected from a pool of thousands. Each winner is handpicked and revolutionary in its own way. Whether they're poised to change the world or simply your living room, the Best of What's New awardees challenge us to the see the future in a new light.” - Cliff Ransom, Executive Editor

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading